Therapeutic Potency of PI3K Pharmacological Inhibitors of Gastrointestinal Cancer

Middle East Journal of Digestive Diseases - Iran
doi 10.15171/mejdd.2018.122
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Maad Rayan Publishing Company

Related search

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors as Cancer Therapeutics

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Role of Immune Checkpoint Inhibitors in Gastrointestinal Cancer Treatment

Memo - Magazine of European Medical Oncology
OncologyHematology
2019English

Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment

Frontiers in Pharmacology
Pharmacology
2020English

Inflammasome Inhibitors: Promising Therapeutic Approaches Against Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

The Impact of PI3K Inhibitors on Breast Cancer Cell and Its Tumor Microenvironment

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2018English

BIOMEDICINE: Picky Inhibitors for PI3K

Science
MultidisciplinaryPhilosophy of ScienceHistory
2005English

A Chemical-Genetic Screen Reveals a Mechanism of Resistance to PI3K Inhibitors in Cancer

Nature Chemical Biology
Cell BiologyMolecular Biology
2011English

Inhibitors Targeting CDK4/6, PARP and PI3K in Breast Cancer: A Review

Therapeutic Advances in Medical Oncology
Oncology
2018English

Small-Molecule Inhibitors of the PI3K Signaling Network

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy